Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Haw Par Corporation Limited

HAWPF•PNK
Healthcare
Drug Manufacturers - General
$14.17
$0.28(2.02%)
U.S. Market opens in 6h 50m

Haw Par Corporation Limited (HAWPF) Stock Overview

Explore Haw Par Corporation Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.1B
P/E Ratio15.87
EPS (TTM)$0.90
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$13.71
3 Months$13.43
1 Year Target$14.75

HAWPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haw Par Corporation Limited (HAWPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 95.20, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $14.75.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.87 and a market capitalization of 3.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.02%
5-Day Change
2.02%
1-Month Change
13.82%
3-Month Change
32.93%
6-Month Change
33.43%
Year-to-Date (YTD) Change
15.86%
1-Year Change
69.30%
3-Year Change
74.94%
5-Year Change
56.75%
All-Time (Max) Change
584.54%

Contact Information

https://www.hawpar.com
65 6337 9102
No. 03-03 Haw Par Technocentre, Singapore, NaN, 149598

Company Facts

IPO DateMar 5, 1996
CountrySG
Actively Trading

Frequently Asked Questions